Диссертация (1174320), страница 26
Текст из файла (страница 26)
12. – P. 93 – 100.189Carpanzano P. Revascularization vs. optimal medical therapy in womenwith NSTE-ACS / Carpanzano P., Tamburino C. // Current PharmaceuticalDesign. – 2016. – Vol. 22 (25). – P. 3905 – 3914.190Gielen S. The Year in Cardiology 2013: cardiovascular disease prevention/ Gielen S., Landmesser U. // European Heart Journal. – 2014. – Vol. 35 (5). –P. 307 – 312.191Hamm C.W. ESC Guidelines for the management of acute coronarysyndromes in patients presenting without ST-segment elevation: the Task147Force for the management of acute coronary syndromes (ACS) in patientspresenting without ST-segment elevation of the European Society ofCardiology (ESC) / Hamm C.W., Bassand J-P., Agewall S.
// European HeartJournal. – 2011. – Vol. 32. – P. 2999 – 3054.192Hamm C.W. Acute coronary syndromes / Hamm C.W., Mollmann H.,Bassand J.-P. // Cardiovascular Medicine. – 2009. – Vol. 9. – P. 15.193Hingorani A.D. C-Reactive protein and coronary heart disease: predictivetest or therapeutic target? / Hingorani A.D., Shah T., Casas J.P. // ClinicalChemistry. – 2009. – Vol. 2.
– P. 239 – 255194Ingelsson E. Hysterectomy and risk of cardiovascular disease: apopulation based cohort study / Ingelsson E., Lundholm C., Johansson A.L. //European Heart Journal. - 2011. – Vol. 32. – P. 45 – 50.195Jackson E.A. Impact of sex on morbidity and mortality rates after lowerextremity interventions for peripheral arterial disease / Jackson E.A., Munir K.,Schreiber T. // Journal of the American College of Cardiology.
– 2014. – Vol.63. – P. 2525 – 2530.196James A.H. Acute myocardial infarction in pregnancy: a United Statespopulation-based study / James A.H., Jamison M.G., Biswas M.S. // Circulation.– 2006. – Vol. 12. – P. 64 – 71.197Januzzi J.L. Circulating proneurotensin concentrations and cardiovasculardisease events in the community. The Framingham Heart Study / Januzzi J.L.,Liu Y., Gaggin H. // Arteriosclerosis, Thrombosis, and Vascular Biology. –2016. – Vol. 36 (8). – P. 1692 – 1697.198John G. Canto.
Symptom presentation of women with acute coronarySyndromes / John G. Canto., Robert J. Goldberg, Mary M. Hand // Arch internmed. – 2007. – Vol. 167. – P. 2405 – 2413.199Keller T. Sensitive troponin I assay in early diagnosis of acute myocardialinfarction / Keller T., Zeller T., Peetz D.
// The New England Journal ofMedicine. – 2009. – Vol. 361. – P. 868 – 877.148200Koopman C. Persisting gender differences and attenuating age differencesin cardiovascular drug use for prevention and treatment of coronary heartdisease, 1998–2010 / Koopman C., Vaartjes I., Heintjes E.M. // European HeartJournal. – 2013.
– Vol. 34. – P. 3198 – 3205.201Kragholm K. Sex-stratified trends in enrollment, patient characteristics,treatment, and outcomes among non-ST-segment elevation acute coronarysyndrome patients: insights from clinical trials over 17 years / Kragholm K.,Halim S.A., Yang Q. // Circulation Cardiovascular Quality and Outcomes. –2015. – Vol. 8 (4). – P. 357 – 367.202Kytö V. Association of age and gender with risk for non-ST-elevationmyocardial infarction / Kytö V., Sipilä J., Rautava P.
// European Journal ofPreventive Cardiology. – 2015. – Vol. 22. – P. 1003 – 1008.203Lander H. Acute myocardial infarction in pregnancy and the puerprenum:a population-based study / Lander H. // Obstetrics and Ginecology. – 2005. –Vol. 3. – P. 480 – 484.204Mancia G. Рекомендации ESH/ESC 2013г. по лечению артериальнойгипертонии / Mancia G., Fegard R., Narkiewicz K. // Системныегипертензии. – 2013. – № 3 (10). – С. 5 – 38.205Mehta S.R. TIMACS Investigators. Early versus delayed intervention inacute coronary syndromes / Mehta S.R., Granger C.B., Boden W.E.
// The NewEngland Journal of Medicine. – 2009. – Vol. 5. – P. 65 – 75.206Melanler O. Validation of plasma proneurotensin as a novel biomarker forthe prediction of incident breast cancer / Melanler O., Belting M., Manjer J. //Cancer Epidemiology, Biomarkers and Prevention. – 2014. – Vol. 23 (8). – P.1672-1676.207Melander O. Proneurotensin may increase risk for CVD, diabetes, breastcancer in women / Melander O. // JAMA. – 2012.
- Vol. 308. – P. 1469 – 1475.208MontalescotG.ABOARDInvestigators.Immediatevsdelayedintervention for acute coronary syndromes: a randomized clinical trial/ Montalescot G., Cayla G., Collet J.P. // JAMA. – 2009. – Vol. 9. – P. 47 – 54.149209Mozaffarian D. Heart disease and stroke statistics - 2016 update. A reportfrom the American heart association / Mozaffarian D., Benjamin E.J., Go A.S. //Circulation.
– 2016. – Vol. 133. – P. 38 – 360.210Mozaffarian D. / Mozaffarian D. // Circulation. – 2015. – Vol. 131. – P.29 - 322.211Müller-Nordhorn J. An update on regional variation in cardiovascularmortality within / Müller-Nordhorn J., Binting S., Roll S. // European HeartJournal. – 2008. – Vol.
29. - P. 1316 – 1326.212Nakatani D. Clinical impact of metabolic syndrome and its additive effectwith smoking on subsequent cardiac events after acute myocardial infarction/Sakata Y., Sato H. et al. on behalf of the Osaka Acute Coronary InsufficiencyStudy Group / Nakatani D. // The American Journal of Cardiology. – 2007. –Vol.
4. – P. 879 – 1026.213Nikpay M. A comprehensive 1000 Genomes–based genome-wideassociation meta-analysis of coronary artery disease / Nikpay M., Goel A., WonH.-H. // Nature Genetics. – 2015. Vol. 47. – P. 1121 – 1130.214Pagidipati N.J. Acute coronary syndromes in women and men / PagidipatiN.J., Peterson E.D. // Nature Reviews Cardiology.
– 2016. – Vol. 13. – P. 471 –480.215PlanerD.Prognosisofpatientswithnon-ST-segment-elevationmyocardial infarction and nonobstructive coronary artery disease: propensitymatched analysis from the Acute Catheterization and Urgent Intervention TriageStrategy tria / Planer D., Mehran R., Ohman E.M.
// Circulation: CardiovascularInterventions. – 2014. – Vol. 7 (3). – P. 285 – 293.216Plichart M. Gender-specific trends in heart rate in the general populationfrom 1992–2007: a study of 226, 288 French adults / Plichart M., Thomas F.,Empana J.-P. // European Journal of Preventive Cardiology. – 2013. - Vol20. – P. 61 – 72.217Reiner Z.
Рекомендации европейского обществ кардиологов и150европейского общества атеросклероза по лечению дислипидемий / ReinerZ., Catapano A.L., Backer G.D. // Рациональная фармакотерапия вкардиологии. – 2012. – №. 15 (8). – С. 3 – 55.218Ridker P.M. C-reactive protein and other markers of inflammation in theprediction of cardiovascular disease in women / Ridker P.M., Hennekens C.H.,Buring J.E. // The New England Journal of Medicine. – 2000. – Vol. 12.
– P.836 – 843.219Ringleb P.A. European Stroke Organisation. Guidelines for managementof ischemic stroke and transient ischemic attack / Ringleb P.A., Bousser M.G.,Ford G. // Cerebrovascular Diseases. – 2008. – Vol. 5. – P. 457 – 507.220Rosamond W. D. Heart disease and stroke statistics – 2012 update: areport from the American Heart Association Statistics Committee and StrokeStatistics Subcommittee / Rosamond W. D.
// Circulation. – 2012. – Vol. 12. –P. 69 – 171.221Schwartz G.G. Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronarysyndrome: An analysis of the Myocardial Ischemia Reduction with AggressiveCholesterol Lowering / Schwartz G.G., Olsson A.G., Szarek M.
// DiadetesCare. – 2005. – Vol. 10. – P. 8 - 13222SicariR.Рекомендацииевропейскойэхокардиографическойассоциации стресс-эхокардиография. Стресс-эхокардиография / Sicari R.,Nihoyannopopulos P., Evangelista A. // Российский кардиологическийжурнал. – 2013. – №. 4 (102). – С. 1 – 28.223Thompson P.L. Acute coronary syndromes in women: differentpresentation and poorer outcomes / Thompson P.L., McQuillan B.M. //Medicine Today. – 2016. – Vol.
17 (5). – P. 16 - 20224Townsend N. Cardiovascular disease statistics / Townsend N., BhatnagarP., Wilkins E. // British Heart Foundation. – 2015. - Chapter 1 mortality. – P. 15– 49.225Wang T.Y. Platelet biology and response to antiplatelet therapy in151women:implicationsforthedevelopmentanduseofantiplateletpharmacotherapies for cardiovascular disease / Wang T.Y., Angiolillo D.J.,Cushman M. // Journal of the American College of Cardiology.
– 2012. – Vol.59. – P. 891 – 900.226Williams R.J.C. Хроническое влияние никотина на частоту сердечныхсокращений / Williams R.J.C. // Международный журнал сердца исосудистых заболеваний. – 2013. – № 1. – С. 20 – 28.227Windecker S. Рекомендации ESC/EACTS по реваскуляризациимиокарда 2014 / Windecker S., Kolh P., Alfonso F. // Российскийкардиологический журнал. – 2015. – №. 2 (118). – С.
21 – 22.228Wiviott S.D. Prasugrel versus clopidogrel in patients with acute coronarysyndromes/ Braunwald E., McCabe C.H. et al. for the TRITON–TIMI 38Investigators / Wiviott S.D. // The New England Journal of Medicine. – 2007. –Vol. 357. – P. 2001 - 2015152ПРИЛОЖЕНИЯПриложение 1. Оценка конечной точкиФИО________________Полных лет_____________1. Как Вы себя чувствуете на данный момент:отличнохорошоудовлетворительноплохоочень плохо2.
Что сейчас Вас беспокоит:________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________3. Дата последней госпитализации:__________________________________4.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
